Alexza Pharma (NASDAQ: ALXA) engages in the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are based on a proprietary technology, the Staccato system, which vaporizes an excipient-free…
Archived Articles
BillMyParents, Inc. (BMPI.OB) Due Diligence.
BillMyParents, Inc. (BMPI.OB) Due Diligence. UPDATED 11/27/12: BillMyParents has entered into a spokesman agreement with Justin Bieber, so the rumors I heard from months ago finally turn out to be correct. I expect more news on this tomorrow to supplement…
Near Term Catalysts For Anacor Pharma Should Make For Nice Upside Gain
Trading biophama companies before a catalyst event, if done correctly, can be a very profitable proposition. Some traders and investors who enjoy bringing more risk into play often times will hold through the actual catalyst event. While this does bring…
Upcoming Catalyst Event For Aveo Pharma May Provoke A Short Squeeze
AVEO Pharmaceuticals (AVEO) is dedicated to discovering, developing and commercializing targeted therapies to impact the lives of patients living with cancer. The company has built a pipeline of anti-cancer therapeutics through the use of its proprietary Human Response Platform™. The…
Small Cap Bio-Pharmas For Possible Long Side Trades
With some added confidence shown by investors yesterday, it’s a good time to look at some “risk on” small cap bio-pharma stocks that I feel offer good upside for both swing trades and longer term holds. However, with the looming…
Explanation On Why Market Could Tank By July 2013
Before and since President Obama won reelection a little over a week ago, the market has been sharply down just about every day. Is this cause for concern? Yes it is, and I will explain why in this write-up. The…
Upcoming BioPharma Catalyst Trades to Consider
Trading BioPhama stocks before a catalyst event, if done correctly can be a very profitable proposition, but if traded in a wrong manner, can cause losses. I remarked in an article from March of this year that Horizon Pharma (NASDAQ:…
5 Biotech Stocks Poised For Nice Upside Gains
The following 5 biotech companies have strong catalysts and/or strong chart signals that indicate a trade to the long side could be in order. With the current choppy markets, opportunities for long trades are few and far between. I will…
Amicus Therapeutics Should See a Big Upside Move On Positive Phase 3 Data
One company that has really received a ton of attention lately has been Sarepta Therapeutics (SRPT). Only a few weeks ago, the stock was trading in the $3 to $4 range. On 10/3/12, the company announced that it received positive…
Quantitative Easing: Fractioning The Dollar, Undervaluing The Markets
On a regular basis, I hear guests on CNBC constantly saying the market is overbought. After awhile, I wonder if these individuals learned about modern finance from a Cracker-Jack box. These same people were screaming at the world in 2008…
